Literature DB >> 14718186

Microcapsules based on glycinin-sodium dodecyl sulfate complex coacervation.

J Lazko1, Y Popineau, D Renard, J Legrand.   

Abstract

Microcapsules processed by complex coacervation were prepared using hexadecane for the oil phase and glycinin (a soybean storage protein)-sodium dodecyl sulfate (SDS) as the main wall-forming material. The study underlines the essential role of SDS, which, by the way of [glycinin(+)-SDS(-)] insoluble complex formation, allowed the precipitation of proteins around oil droplets. Moreover, particular attention was attributed to the study of suitable conditions of glycinin cross-linking with glutaraldehyde. The reticulation step was performed at pH 4.0 and it was observed that the precipitated state of proteins increased considerably the efficiency of the cross-linking reaction. Analysis of the reactional medium after each main step of the process (emulsification, complex coacervation, cross-linking) allowed the follow-up and characterization of microcapsule formation. Optimization of different process parameters such as glycinin concentration, glycinin/SDS/glutaraldehyde ratios, pH and the kinetics of cross-linking allowed the encapsulation of the totality of oil and the use of more than 98% of initially introduced proteins for the microcapsule wall formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718186     DOI: 10.1080/02652040310001619785

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  2 in total

1.  Complex coacervation of lysozyme and heparin: complex characterization and protein stability.

Authors:  Marco van de Weert; Mia Bendix Andersen; Sven Frokjaer
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

Review 2.  Protein-Polysaccharide Composite Materials: Fabrication and Applications.

Authors:  Elizabeth J Bealer; Shola Onissema-Karimu; Ashley Rivera-Galletti; Maura Francis; Jason Wilkowski; David Salas-de la Cruz; Xiao Hu
Journal:  Polymers (Basel)       Date:  2020-02-17       Impact factor: 4.329

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.